166 related articles for article (PubMed ID: 37183232)
1. Are dietary and serum advanced glycation end-products related to inflammation and oxidation biomarkers in breast cancer patients: a follow-up study.
Alkan ŞB; Artaç M; Aksoy F; Belviranlı MM; Gürbilek M; Çizmecioğlu HA; Rakıcıoğlu N
Support Care Cancer; 2023 May; 31(6):334. PubMed ID: 37183232
[TBL] [Abstract][Full Text] [Related]
2. Dietary intake of advanced glycation end products did not affect endothelial function and inflammation in healthy adults in a randomized controlled trial.
Semba RD; Gebauer SK; Baer DJ; Sun K; Turner R; Silber HA; Talegawkar S; Ferrucci L; Novotny JA
J Nutr; 2014 Jul; 144(7):1037-42. PubMed ID: 24744309
[TBL] [Abstract][Full Text] [Related]
3. Contribution of dietary advanced glycation end products (AGE) to circulating AGE: role of dietary fat.
Davis KE; Prasad C; Vijayagopal P; Juma S; Adams-Huet B; Imrhan V
Br J Nutr; 2015 Dec; 114(11):1797-806. PubMed ID: 26392152
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of the advanced glycation end product carboxymethyl lysine in breast cancer is positively associated with estrogen receptor expression and unfavorable prognosis in estrogen receptor-negative cases.
Nass N; Ignatov A; Andreas L; Weißenborn C; Kalinski T; Sel S
Histochem Cell Biol; 2017 May; 147(5):625-634. PubMed ID: 28012130
[TBL] [Abstract][Full Text] [Related]
5. Dietary protein intake and circulating advanced glycation end product/receptor for advanced glycation end product concentrations in the Health, Aging, and Body Composition Study.
Brinkley TE; Semba RD; Kritchevsky SB; Houston DK;
Am J Clin Nutr; 2020 Dec; 112(6):1558-1565. PubMed ID: 33301008
[TBL] [Abstract][Full Text] [Related]
6. Advanced glycation end products in infant formulas do not contribute to insulin resistance associated with their consumption.
Klenovics KS; Boor P; Somoza V; Celec P; Fogliano V; Sebeková K
PLoS One; 2013; 8(1):e53056. PubMed ID: 23301020
[TBL] [Abstract][Full Text] [Related]
7. Dietary advanced glycation end products are associated with an increased risk of breast cancer in Iranian adults.
Jahromi MK; Tehrani AN; Farhadnejad H; Emamat H; Ahmadirad H; Teymoori F; Heidari Z; Saber N; Rashidkhani B; Mirmiran P
BMC Cancer; 2023 Oct; 23(1):932. PubMed ID: 37789296
[TBL] [Abstract][Full Text] [Related]
8. The Evaluation of Dietary Antioxidant Capacity, Dietary Inflammatory Index and Serum Biomarkers in Breast Cancer: A Prospective Study.
Alkan ŞB; Artaç M; Aksoy F; Belviranlı MM; Gürbilek M; Akay Çizmecioğlu H; Rakıcıoğlu N
Nutr Cancer; 2023; 75(8):1625-1637. PubMed ID: 37353899
[TBL] [Abstract][Full Text] [Related]
9. Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: a study protocol for a double-blind placebo-controlled randomised crossover clinical trial.
Kellow NJ; Coughlan MT; Savige GS; Reid CM
BMC Endocr Disord; 2014 Jul; 14():55. PubMed ID: 25011647
[TBL] [Abstract][Full Text] [Related]
10. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.
Palma-Duran SA; Kontogianni MD; Vlassopoulos A; Zhao S; Margariti A; Georgoulis M; Papatheodoridis G; Combet E
Metabolism; 2018 Jun; 83():120-127. PubMed ID: 29409822
[TBL] [Abstract][Full Text] [Related]
11. Dietary consumption of advanced glycation end products and pancreatic cancer in the prospective NIH-AARP Diet and Health Study.
Jiao L; Stolzenberg-Solomon R; Zimmerman TP; Duan Z; Chen L; Kahle L; Risch A; Subar AF; Cross AJ; Hollenbeck A; Vlassara H; Striker G; Sinha R
Am J Clin Nutr; 2015 Jan; 101(1):126-34. PubMed ID: 25527756
[TBL] [Abstract][Full Text] [Related]
12. Plasma Levels of Free
Helou C; Nogueira Silva Lima MT; Niquet-Leridon C; Jacolot P; Boulanger E; Delguste F; Guilbaud A; Genin M; Anton PM; Delayre-Orthez C; Papazian T; Howsam M; Tessier FJ
Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565855
[TBL] [Abstract][Full Text] [Related]
13. Dietary intake of advanced glycation endproducts is associated with higher levels of advanced glycation endproducts in plasma and urine: The CODAM study.
Scheijen JLJM; Hanssen NMJ; van Greevenbroek MM; Van der Kallen CJ; Feskens EJM; Stehouwer CDA; Schalkwijk CG
Clin Nutr; 2018 Jun; 37(3):919-925. PubMed ID: 29381139
[TBL] [Abstract][Full Text] [Related]
14. Dietary and serum advanced glycation end-products and clinical outcomes in breast cancer.
Peterson LL; Ligibel JA
Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):188995. PubMed ID: 37806640
[TBL] [Abstract][Full Text] [Related]
15. Action of metformin therapy against advanced glycation, oxidative stress and inflammation in type 2 diabetes patients: 3 months follow-up study.
Adeshara KA; Bangar NS; Doshi PR; Diwan A; Tupe RS
Diabetes Metab Syndr; 2020; 14(5):1449-1458. PubMed ID: 32769032
[TBL] [Abstract][Full Text] [Related]
16. Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging.
Uribarri J; Cai W; Peppa M; Goodman S; Ferrucci L; Striker G; Vlassara H
J Gerontol A Biol Sci Med Sci; 2007 Apr; 62(4):427-33. PubMed ID: 17452738
[TBL] [Abstract][Full Text] [Related]
17. Dietary intake associated with serum versus urinary carboxymethyl-lysine, a major advanced glycation end product, in adults: the Energetics Study.
Semba RD; Ang A; Talegawkar S; Crasto C; Dalal M; Jardack P; Traber MG; Ferrucci L; Arab L
Eur J Clin Nutr; 2012 Jan; 66(1):3-9. PubMed ID: 21792213
[TBL] [Abstract][Full Text] [Related]
18. Presence of dopa and amino acid hydroperoxides in proteins modified with advanced glycation end products (AGEs): amino acid oxidation products as a possible source of oxidative stress induced by AGE proteins.
Fu S; Fu MX; Baynes JW; Thorpe SR; Dean RT
Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):233-9. PubMed ID: 9461515
[TBL] [Abstract][Full Text] [Related]
19. Overweight Women with Breast Cancer on Chemotherapy Have More Unfavorable Inflammatory and Oxidative Stress Profiles.
L D Santos L; D D Custódio I; Silva ATF; C C Ferreira I; C Marinho E; C Caixeta D; V Souza A; R Teixeira R; Araújo TG; Shivappa N; R Hébert J; Paiva CE; S Espíndola F; Goulart LR; C P Maia Y
Nutrients; 2020 Oct; 12(11):. PubMed ID: 33126617
[TBL] [Abstract][Full Text] [Related]
20. Hepatic Fat Content and Liver Enzymes Are Associated with Circulating Free and Protein-Bound Advanced Glycation End Products, Which Are Associated with Low-Grade Inflammation: The CODAM Study.
Bijnen M; van Greevenbroek MMJ; van der Kallen CJH; Scheijen JL; van de Waarenburg MPH; Stehouwer CDA; Wouters K; Schalkwijk CG
J Diabetes Res; 2019; 2019():6289831. PubMed ID: 31218233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
